AA

Abeer Agarwal

Active Director Director DIN 10194566
DIN 10194566 First appointment Jun 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2023
Shareholding value Locked Premium profile

About Abeer Agarwal

Abeer Agarwal has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Pharmtak Ophthalmics (I) Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10194566
Primary Designation Director
First Appointment 09 Jun 2023
Oldest Company Age 30 yrs

Current companies

Company Designation Appointment Founded Status
Director 09 Jun 2023 1996 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmtak Ophthalmics (I) Private Limited
Premium access

Shareholding and investment profile for Abeer Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abeer Agarwal

Abeer Agarwal has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Pharmtak Ophthalmics (I) Private Limited. Engaged in General Business. Contributes to corporate operations.

Abeer Agarwal is associated with 1 company as Director.

Abeer Agarwal has expertise in General Business.

Abeer Agarwal has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available